A 67-year-old woman with a history of schizoaffective disorder, diabetes mellitus, hypertension and hyperlipidemia was taken by her daughter to a psychiatric office due to behavioral changes.
His medication was 600 mg daily of lithium, 400 mg quetiapine twice daily, insulin, empagliflo, metformin, atorvastatin, irbesartan and aspirin.
On physical examination she was unrestricted, with no acute distress.
His speech was unintelligible.
He was disoriented about time, space, and people.
His vital signs were: respiratory rate 18 r.p.m., ambient temperature1 o.C, pulse 100 l.p.m., blood pressure 145/82 mmHg and oxygen saturation (SpO2) 93% in the abdomen.
Pulmonary examination revealed weak crackles.
The analytical tests showed white blood cell count 7.78 x 103 cells per millimeter gave a concentration (/mm3) with 9.4% lymphocytes, high creatinine (Cr) to 1.35 milligrams per decitrodl (mg/dl).
The electrocardiogram was normal.
A head C.T.‚ñÅ~~~ scan didn't give relevant results.
A chest X-ray showed bilateral patchy infiltrates.
A nasopharyngeal swab for SARS-CoV-2 analyzed by RT-PCR was positive.
He was admitted to the general ward due to pneumonia caused by COVID-19, acute kidney injury and lithium poisoning.
On the first day of admission, four patients received normal saline i.v.
to treat lithium poisoning and acute kidney injury.
No acute worsening of symptoms of COVID-19 was observed after intravenous fluid administration.
and he had good diuresis.
Her mental status improved and lithium levels returned to normal.
He received hydroxychloroquine to treat COVID-19 according to the hospital protocol; however, his evolution was complicated due to acute hypoxemic respiratory failure and finally died on day 4 of admission.
